Organigram Global Inc. filings document the disclosures of a Canadian cannabis company listed on Nasdaq and the TSX. Its Form 6-K reports furnish news releases, material change reports, shareholder meeting materials, proxy forms and other exhibits covering operating results, product announcements, material agreements and corporate events.
The company’s regulatory record includes disclosure about licensed cultivation and processing, adult-use cannabis brands, cannabinoid beverages, the FAST nanoemulsion technology platform, Health Canada regulation, capital-structure matters, shareholder voting, board and committee governance, and director and executive compensation practices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.49%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.12%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.2%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.63%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
FAQ
How many ORGANIGRAM GLOBAL (OGI) SEC filings are available on StockTitan?
StockTitan tracks 37 SEC filings for ORGANIGRAM GLOBAL (OGI), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for ORGANIGRAM GLOBAL (OGI)?
The most recent SEC filing for ORGANIGRAM GLOBAL (OGI) was filed on October 29, 2025.